Back

Ambler class C-type β-lactamases in Enterobacter spp. and Klebsiella aerogenes in the Netherlands, 2012-2023

van Gorp, E.; Lansu, S.; Wielders, C. C. H.; de Haan, A.; Godeke, G.-J.; Witteveen, S.; Bos, J.; Landman, F.; Ouw, M.; Wunderink, H. F.; van Meer, M. P. A.; van der Zwet, W.; Notermans, D. W.; Hendrickx, A. P. A.; Dutch CPE Surveillance Study Group,

2025-02-21 public and global health
10.1101/2025.02.19.25322487 medRxiv
Show abstract

We investigated the genomic epidemiology of Ambler class C (AmpC-type) {beta}-lactamases in Enterobacter spp. and Klebsiella aerogenes in the national carbapenemase-producing Enterobacterales (CPE) surveillance of the Netherlands between 2012 and 2023. A total of 399 E. cloacae complex and K. aerogenes isolates from 399 patients were analyzed using whole-genome sequencing to assess genetic relatedness, resistance gene profiles, plasmid replicons, and the genomic location of AmpC-genes, respectively. Of the 399 patients, 217 were male (54%), and the median age was 67 years. Carbapenemase production was assessed using the carbapenem inactivation method (CIM) and CarbaNP-test. Considerable proportions of Enterobacter spp. (32%) and K. aerogenes (52%) isolates produced carbapenemase, without detectable major carbapenemase genes (IMP, KPC, NDM, OXA-48-like, VIM), a phenotype termed CIM+Carba-. These isolates were mostly (82%) susceptible (EUCAST [≤]2mg/L) to meropenem. The majority of CIM+Carba+ isolates with major carbapenemase genes were gained from pre-emptive screening, while CIM+Carba-isolates were mainly taken for diagnostic purposes. Genomic analysis identified 18 genogroups, with E. kobei, E. roggenkampii, E. ludwigii, and K. aerogenes showing the CIM+Carba-phenotype, correlating with chromosome-encoded AmpC-type {beta}-lactamases like blaACT-28, blaACT-52, blaMIR-3, blaMIR-11 or ampC of which the majority (63%) yielded a positive CarbaNP. These CIM+Carba-isolates carried only few plasmids, and there was limited nosocomial spread. CIM+Carba-E. kobei carrying blaACT-28 overproduced ACT-28 protein in the CIM. Overall, the Enterobacter and K. aerogenes population in the Netherlands is genetically diverse, with most isolates carrying species-specific AmpC-type {beta}-lactamases with putative carbapenemase activity and represent a low-risk for public health. ImportanceCPE represents an important healthcare problem worldwide. This study highlights the diverse genetic Enterobacter spp. population in the Dutch CPE surveillance with E. hormaechei subsp. steigerwaltii as the most common carbapenemase-producing (CIM+Carba+) species. However, a significant proportion of E. kobei, E. roggenkampii, E. ludwigii, and K. aerogenes obtained in the Netherlands carry chromosomal AmpC-type {beta}-lactamases with putative carbapenemase activity in the absence of major carbapenemases (CIM+Carba-), were mostly susceptible for meropenem, and showed limited nosocomial spread. We recommend whole-genome sequencing for accurate Enterobacter/K. aerogenes species classification, and AmpC-type {beta}-lactamase gene identification. Despite limited carbapenem resistance and dissemination, proper infection control measures are necessary. The work outlined here underscores the importance of distinguishing E. kobei, E. roggenkampii, E. ludwigii, and K. aerogenes isolates and its AmpC-type {beta}-lactamases from true CPE by whole-genome sequencing to avoid misclassification and unnecessary infection prevention and public health interventions.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
JAC-Antimicrobial Resistance
14 papers in training set
Top 0.1%
18.5%
2
Microbiology Spectrum
469 papers in training set
Top 0.6%
11.9%
3
PLOS ONE
5266 papers in training set
Top 22%
7.9%
4
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.2%
6.2%
5
Eurosurveillance
83 papers in training set
Top 0.1%
5.5%
6
Microorganisms
106 papers in training set
Top 0.3%
4.3%
50% of probability mass above
7
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 0.7%
4.0%
8
Scientific Reports
3612 papers in training set
Top 26%
4.0%
9
Journal of Clinical Microbiology
130 papers in training set
Top 0.5%
3.2%
10
Frontiers in Microbiology
427 papers in training set
Top 4%
2.4%
11
Genome Medicine
183 papers in training set
Top 2%
2.1%
12
Emerging Infectious Diseases
105 papers in training set
Top 0.7%
2.0%
13
Microbiology Resource Announcements
25 papers in training set
Top 0.2%
1.9%
14
mSystems
394 papers in training set
Top 4%
1.9%
15
BMC Infectious Diseases
133 papers in training set
Top 2%
1.9%
16
eLife
5828 papers in training set
Top 52%
1.5%
17
Clinical Microbiology and Infection
62 papers in training set
Top 0.5%
1.1%
18
mSphere
302 papers in training set
Top 5%
1.1%
19
Nature Communications
5641 papers in training set
Top 51%
1.1%
20
Frontiers in Public Health
148 papers in training set
Top 5%
1.1%
21
Antimicrobial Resistance & Infection Control
11 papers in training set
Top 0.1%
1.1%
22
Microbial Genomics
225 papers in training set
Top 2%
1.0%
23
BMC Genomics
406 papers in training set
Top 8%
0.8%
24
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.8%
25
Clinical Infectious Diseases
235 papers in training set
Top 3%
0.8%
26
International Journal of Systematic and Evolutionary Microbiology
14 papers in training set
Top 0.3%
0.6%
27
Epidemiology and Infection
89 papers in training set
Top 3%
0.6%
28
Journal of Hospital Infection
29 papers in training set
Top 0.5%
0.6%